Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13


Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.

Snippenburg W, Nellen F, Smit C, Wensing A, Godfried MH, Mudrikova T.

J Virus Erad. 2017 Jan 1;3(1):34-39.


Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.

Gill MM, Hoffman HJ, Bobrow EA, Mugwaneza P, Ndatimana D, Ndayisaba GF, Baribwira C, Guay L, Asiimwe A.

PLoS One. 2016 Dec 22;11(12):e0168671. doi: 10.1371/journal.pone.0168671. eCollection 2016.


Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.

Williams PL, Hazra R, Van Dyke RB, Yildirim C, Crain MJ, Seage GR 3rd, Civitello L, Ellis A, Butler L, Rich K; Pediatric HIV/AIDS Cohort Study.

AIDS. 2016 Jan 2;30(1):133-44. doi: 10.1097/QAD.0000000000000916.


Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.

Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A, Yehia BR.

PLoS One. 2015 Jul 1;10(7):e0132262. doi: 10.1371/journal.pone.0132262. eCollection 2015.


Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.

Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R.

Ann Intern Med. 2015 Jan 20;162(2):90-9. doi: 10.7326/M13-2005.


Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012.

Rough K, Tassiopoulos K, Kacanek D, Griner R, Yogev R, Rich KC, Seage GR 3rd; Pediatric HIVAIDS Cohort Study.

AIDS. 2015 Jan 2;29(1):117-23. doi: 10.1097/QAD.0000000000000503.


Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

Samuel M, Bradshaw D, Perry M, Chan SY, Dhairyawan R, Byrne L, Smith K, Zhou J, Short CE, Naftalin C, Offodile N, Mandalia S, Roedling S, Shah R, Brook G, Poulton M, Rodgers M, Sarner L, Noble H, Hay P, Anderson J, Natha M, Hawkins D, Taylor G, de Ruiter A.

Infect Dis Obstet Gynecol. 2014;2014:961375. doi: 10.1155/2014/961375. Epub 2014 Sep 25.


Validation of the Gen-Probe Aptima qualitative HIV-1 RNA assay for diagnosis of human immunodeficiency virus infection in infants.

Fiscus SA, McMillion T, Nelson JA, Miller WC.

J Clin Microbiol. 2013 Dec;51(12):4137-40. doi: 10.1128/JCM.01525-13. Epub 2013 Oct 2.


Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.

Denoeud-Ndam L, Fourcade C, Ogouyemi-Hounto A, Azon-Kouanou A, d'Almeida M, Azondékon A, Alao MJ, Dossou-Gbété V, Afangnihoun A, Girard PM, Cot M, Zannou DM.

PLoS One. 2013;8(3):e59446. doi: 10.1371/journal.pone.0059446. Epub 2013 Mar 15.


The impact of African ethnicity and migration on pregnancy in women living with HIV in the UK: design and methods.

Tariq S, Pillen A, Tookey PA, Brown AE, Elford J.

BMC Public Health. 2012 Aug 2;12:596. doi: 10.1186/1471-2458-12-596.


Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.

Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA; European Collaborative Study; National Study of HIV in Pregnancy Childhood.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):326-33. doi: 10.1097/QAI.0b013e31821d34d0. Erratum in: J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):e117.


Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy).

Izzo I, Forleo MA, Casari S, Quiros-Roldan E, Magoni M, Carosi G, Torti C.

BMC Public Health. 2011 Feb 21;11:124. doi: 10.1186/1471-2458-11-124.


Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.

Tassiopoulos K, Read JS, Brogly S, Rich K, Lester B, Spector SA, Yogev R, Seage GR 3rd.

AIDS Behav. 2010 Dec;14(6):1269-78. doi: 10.1007/s10461-010-9705-0.

Supplemental Content

Support Center